TPO-RAs have been found to improve trilineage hematopoiesis in aplastic anemia patients despite the presence of high levels of endogenous thrombopoietin [43], which suggests that analogs may exert this effect using alternative anti-inflammatory mechanisms [44]. This evidence concerns the gene TPO and idiopathic aplastic anemia.